ClinicalTrials.Veeva

Menu

Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins (RESIRUPT)

C

Centre Hospitalier le Mans

Status

Not yet enrolling

Conditions

Prelabor Rupture of Membranes

Treatments

Other: Additional rupture of the residual membrane

Study type

Interventional

Funder types

Other

Identifiers

NCT07301957
CHM-2023/S30/07

Details and patient eligibility

About

Approximately 25% of patients experience premature rupture of membranes before labour. Of these patients, 82% will give birth within 24 hours and 97% within 48 hours.

Patients who do not go into labour spontaneously will be induced 24 or 48 hours after their membranes rupture, depending on the centre.

During this period, they are hospitalised in the obstetrics department. The presence of a residual membrane appears to prolong the latency period before labour begins and the rate of induction, according to a pilot study conducted by investigator.

No study specifically addresses this topic. The various studies on "Rupture of Membranes Before Labour" assess its frequency of occurrence or the time before considering induction. They also assess the occurrence of maternal-foetal infection. This is no longer of interest today, as antibiotic prophylaxis has significantly reduced maternal-foetal infections.

Investigator would therefore like to assess the impact of additional rupture of the residual membrane upon the patient's admission on the latency before labour and the induction rate (for membrane rupture exceeding 48 hours.

Enrollment

130 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women over 18 years of age
  • Single foetal pregnancy, cephalic presentation
  • diagnosis of membrane rupture with persistence of one membrane and absence of immediate spontaneous labour.
  • Person affiliated with or beneficiary of a social security scheme
  • Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).

Exclusion criteria

  • Minor patient
  • patient under guardianship/curatorship,
  • multiple pregnancy, pregnancy with foetal death
  • non-cephalic presentation
  • gestational age less than 37 weeks,
  • rupture of membranes more than 12 hours ago
  • contraindication to vaginal deliver
  • meconium-stained amniotic fluid,
  • clinical signs suggestive of intrauterine infection (maternal hyperthermia >38°C, maternal and/or foetal tachycardia, purulent amniotic fluid),
  • cervix not accessible for artificial rupture
  • vaginismus
  • contraindication to a potential expectant management
  • indication for induction for another reason

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

130 participants in 2 patient groups

Additional rupture of the residual membrane
Experimental group
Description:
Rupture of the residual membrane
Treatment:
Other: Additional rupture of the residual membrane
Standard of care
No Intervention group
Description:
unbroken residual membrane

Trial contacts and locations

2

Loading...

Central trial contact

Christelle JADEAU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems